256 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
17 Apr 24
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
7:30am
reductions in ventricular arrythmias in a rat heart model of diabetes with restricted and restored coronary blood flow induced injury.
Announced
8-K
EX-2.1
WINT
Windtree Therapeutics Inc
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
from any injury to any individual or property with respect to any of the Products.
Section 3.9. Inventory. Section 3.9 of the Disclosure Schedule
424B4
WINT
Windtree Therapeutics Inc
20 Apr 23
Prospectus supplement with pricing info
6:03pm
to claims resulting from unintended effects that result in injury or death. Product liability claims alleging inadequate disclosure and warnings in our … product candidates, or any materials that we use in our product candidates allegedly causes injury or is found to be otherwise unsuitable during
8-K
EX-99.1
2poctcer9g cdxl2q
5 May 22
Windtree Therapeutics Reports First Quarter 2022 Financial Results and Provides Key Business Updates
4:04pm
8-K
EX-99.1
rwo7jns4fio35 1hjv
31 Mar 22
Windtree Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Key Business Updates
7:05am
8-K
EX-99.1
26irzn7rte4 44idg3p
5 Aug 21
Windtree Therapeutics Reports Second Quarter 2021 Financial Results and Provides Key Business Updates
5:31pm
8-K
EX-99.1
6g2qnbeex19wj5mpk
13 May 21
Windtree Therapeutics Reports First Quarter 2021 Financial Results and Provides Key Business Updates
7:34am